United States · Investor

Hercules Capital

Last cheque observed Oct 2026; 92 cheques on record.

Venture debtDeploying nowNew fund $323M, Oct 2025

GrowthLife SciencesTechnology

Deploying now
87%of best year13cheques in 12 months, 92 on record
Since the last cheque22days00hrs00min00sec
Median round$91MRounds led0 of 92Sole investor39 roundsExits12 from the portfolioMostly inUnited States, 79%
Pitch Hercules Capital

Hercules Capital highlights

  1. 01

    13 cheques in the last 12 months

  2. 02

    Mostly Debt and Venture: 81% of its rounds

  3. 03

    Sole investor in 39 rounds, median $15M

  4. 04

    12 exits from the portfolio

What they do

Hercules Capital is the largest business development company focused on venture lending, and the lender of choice for innovative entrepreneurs and their venture capital partners.From their own website
Type
Venture debt
Cheque size
Not stated
Stages
Growth
Sectors
Life SciencesTechnology
Based in
San Mateo, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first92 appearances

  1. 2026

    12 rounds

  2. Oct
    SukiSeries E · US · Google News search$90MWith 7 others
  3. Oct
    CapitolisSeries E · US · AlleyWatch$120MWith 11 others
  4. Sept
    Locus RoboticsGrowth · US$42MWith 3 others
  5. Jul
    BehavoxGrowth · Ventureburn$175MWith 5 others
  6. Jun
    PerkDebt · GB · Ventureburn$300MWith 7 others
  7. Jun
    4D Molecular TherapeuticsDebt · US$200MWith 3 others
  8. Jun
    EloxxUS$66MWith 2 others
  9. Jun
    MoonLake ImmunotherapeuticsCH$200MWith 2 others
  10. Mar
    IntercomDebt · IE · Ventureburn$250MSole investor
  11. Feb
    HypercoreSeries A · IL · Ventureburn$14MWith 5 others
  12. Jan
    Phathom PharmaceuticalsUS$130MWith 3 others
  13. Jan
    FunnelDebt · SE$80MWith 3 others
  14. 2025

    11 rounds

  15. Dec
    Dyne TherapeuticsUS$403MWith 3 others
  16. Nov
    MoonLake ImmunotherapeuticsCH$75MWith 2 others
  17. Nov
    Verastem OncologyUS$90MWith 4 others
  18. Oct
    X4 PharmaceuticalsUS$155MWith 5 others
  19. Oct
    GoviniGrowth · US$150MWith 2 others
  20. Aug
    SnapptDebt · US$50MWith 3 others
  21. Jul
    Madrigal PharmaceuticalsDebt · US$350MWith 1 other
  22. Jun
    CarbyneVenture · US$100MWith 3 others
  23. May
    Axsome TherapeuticsDebt · US$570MWith 1 other
  24. Apr
    Main Street HealthVenture · US$32MWith 2 others
  25. Feb
    Genetix Biotherapeutics Inc.Venture · USUndisclosedWith 4 others
  26. 2024

    11 rounds

  27. Dec
    Remodel HealthVenture · US$100MSole investor
  28. Nov
    Replimune GroupUS$140MWith 5 others
  29. Nov
    RumbleONUS$10MSole investor
  30. Oct
    SynOx TherapeuticsSeries B · IE$92MWith 1 other
  31. Jul
    CarwowVenture · GB$52MWith 4 others
  32. Jun
    SemperisDebt · US$125MWith 4 others
  33. May
    Electric HydrogenDebt · US$100MWith 4 others
  34. Apr
    Gritstone bioUS$33MWith 3 others
  35. Jan
    Kura OncologyUS$150MWith 2 others
  36. Jan
    Better TherapeuticsUS$250KSole investor
  37. Jan
    Sight SciencesDebt · US$35MSole investor
  38. 2023

    2 rounds

  39. Nov
    AmplifyBioVenture · US$50MSole investor
  40. Feb
    Provention BioUS$35MWith 2 others
  41. 2022

    8 rounds

  42. Nov
    Oak Street HealthDebt · US$300MWith 2 others
  43. Aug
    Alladapt ImmunotherapeuticsDebt · US$50MWith 1 other
  44. Aug
    ZeroFoxUS$170MWith 4 others
  45. May
    Phathom PharmaceuticalsDebt · US · Firms' own news pages$260MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration3 named

KZKiersten Zaza BotelhoGeneral Counsel and Chief Compliance Officer of the Investment ManageriFiling they signed
SBScott BluesteinPresident and Chief Executive Officer of the Investment ManageriFiling they signed
SHSeth Hardy MeyerChief Financial Officer and Chief Accounting Officer of the Investment ManageriFiling they signed

We also hold 44 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$1.6Bassets it managesOct 2026
1+funds on filenumbered funds in its name
Registeredinvestment adviserfull reporting to the SEC
Legal name
Hercules Adviser LLC
SEC number
CRD 310662

Funds on its Form ADV

3 private funds, $1.1B in gross assets · filed Mar 2024

  1. Hercules Private Credit Fund 1, L.P.Hedge2 investors$537M
  2. Hercules Private Global Venture Growth Fund I L.P.Hedge10 investors$442M
  3. Hercules Venture Growth Credit Opportunities Fund 1 L.P.Hedge1 investor$102M

What they claim to have backed

From their own portfolio page (on their website)

0 of 1 we have independently watched raise

Cookiedatabase

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Exits from the portfolio

Companies it backed that were later bought or listed12 in all

UnifyBought by AtosUndisclosedNov 2015
AtrentaBought by SynopsysUndisclosedJun 2015
IKANO CommunicationsBought by BroadvoiceUndisclosedFeb 2015
iWattBought by Dialog Semiconductor$345MJul 2013
hi5Bought by if(we)UndisclosedDec 2011
InfoLogixBought by Stanley Black & Decker$61MDec 2010
Memory PharmaceuticalsBought by Roche$50MNov 2008
CompeteBought by Taylor Nelson Sofres$150MMar 2008
AGEIA TechnologiesBought by NvidiaUndisclosedFeb 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Hercules Capital. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Hercules Capital put money into.

Mentioned on podcasts

Episodes that name Hercules Capital in their description, not their title.

Quick answers about Hercules Capital

What does Hercules Capital invest in?

Hercules Capital invests most often at Debt and Venture (81% of the rounds on record), in sectors such as Life Sciences and Technology.

How active is Hercules Capital?

92 investments on record, 13 of them in the last 12 months. The most recent was in Oct 2026.

What has Hercules Capital invested in recently?

Its most recent investments on record: Suki (Series E, Oct 2026), Capitolis (Series E, Oct 2026) and Locus Robotics (Growth, Sept 2026).

How big are Hercules Capital's cheques?

The median round it joins is $91M.

Does Hercules Capital lead rounds?

Rarely, if at all: none of its 92 investments on record names it as the lead.

Where does Hercules Capital invest?

Most of the companies it backs are in the United States (79%), the United Kingdom (5%) and Switzerland (5%).

Is Hercules Capital investing now?

Yes: it is actively investing, with 13 investments in the last 12 months.

Who does Hercules Capital invest alongside?

Most often Cormorant Asset Management (5 rounds together), Forbion Capital Partners (4 rounds together) and New Enterprise Associates (4 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it